TY - JOUR
T1 - Comparative Analysis of Inpatient Opioid Consumption Between Different Surgical Approaches Following Single Level Lumbar Spinal Fusion Surgery
AU - Zabat, Michelle A.
AU - Mottole, Nicole A.
AU - Ashayeri, Kimberly
AU - Norris, Zoe A.
AU - Patel, Hershil
AU - Sissman, Ethan
AU - Balouch, Eaman
AU - Maglaras, Constance
AU - Protopsaltis, Themistocles S.
AU - Buckland, Aaron J.
AU - Fischer, Charla R.
N1 - Publisher Copyright:
© The Author(s) 2022.
PY - 2023/10
Y1 - 2023/10
N2 - Study Design: Single-center retrospective cohort study Objectives: To evaluate inpatient MME administration associated with different lumbar spinal fusion surgeries Methods: Patients ≥18 years of age with a diagnosis of Grade I or II spondylolisthesis, stenosis, degenerative disc disease or pars defect who underwent one-level Transforaminal Lumbar Interbody Fusion (TLIF) or one-level Anterior Lumbar Interbody Fusion (ALIF) or Lateral Lumbar Interbody Fusion (LLIF) through traditional MIS, anterior-posterior position or single position approaches between L2-S1. Outcome measures included patient demographics, surgical procedure and approach, perioperative clinical characteristics, incidence of ileus and inpatient MME. Statistical analysis included one-way ANOVA with a post-hoc Tukey Test and Kruskal–Wallis Test with post-hoc Mann–Whitney test. MME was calculated as per the Centers for Medicare and Medicaid Services and previous literature. Significance set at P <.05. Results: Mean age differed significantly between MIS TLIF (55.6 ± 12.5 years) and all other groups (Open TLIF 57.1 ± 12.5, SP ALIF/LLIF 57.9 ± 9.9, TP ALIF/LLIF 50.9 ± 12.7, Open ALIF/LLIF 58.4 ± 15.5). MIS TLIF had the shortest LOS compared to all groups except SP ALIF/LLIF. Total MME was significantly different between MIS TLIF and Open ALIF/LLIF (172.5 MME vs 261.1 MME, P =.044) as well as MIS TLIF and TP ALIF/LLIF (172.5 MME vs 245.4 MME, P =.009). There were no significant differences in MME/hour and incidence of ileus between all groups. Conclusion: Patients undergoing MIS TLIF had lower inpatient opioid intake compared to TP and SP ALIF/LLIF, as well as shorter LOS compared to all groups except SP ALIF/LLIF. Thus, it appears that the advantages of minimally invasive surgery are seen in minimally invasive TLIFs.
AB - Study Design: Single-center retrospective cohort study Objectives: To evaluate inpatient MME administration associated with different lumbar spinal fusion surgeries Methods: Patients ≥18 years of age with a diagnosis of Grade I or II spondylolisthesis, stenosis, degenerative disc disease or pars defect who underwent one-level Transforaminal Lumbar Interbody Fusion (TLIF) or one-level Anterior Lumbar Interbody Fusion (ALIF) or Lateral Lumbar Interbody Fusion (LLIF) through traditional MIS, anterior-posterior position or single position approaches between L2-S1. Outcome measures included patient demographics, surgical procedure and approach, perioperative clinical characteristics, incidence of ileus and inpatient MME. Statistical analysis included one-way ANOVA with a post-hoc Tukey Test and Kruskal–Wallis Test with post-hoc Mann–Whitney test. MME was calculated as per the Centers for Medicare and Medicaid Services and previous literature. Significance set at P <.05. Results: Mean age differed significantly between MIS TLIF (55.6 ± 12.5 years) and all other groups (Open TLIF 57.1 ± 12.5, SP ALIF/LLIF 57.9 ± 9.9, TP ALIF/LLIF 50.9 ± 12.7, Open ALIF/LLIF 58.4 ± 15.5). MIS TLIF had the shortest LOS compared to all groups except SP ALIF/LLIF. Total MME was significantly different between MIS TLIF and Open ALIF/LLIF (172.5 MME vs 261.1 MME, P =.044) as well as MIS TLIF and TP ALIF/LLIF (172.5 MME vs 245.4 MME, P =.009). There were no significant differences in MME/hour and incidence of ileus between all groups. Conclusion: Patients undergoing MIS TLIF had lower inpatient opioid intake compared to TP and SP ALIF/LLIF, as well as shorter LOS compared to all groups except SP ALIF/LLIF. Thus, it appears that the advantages of minimally invasive surgery are seen in minimally invasive TLIFs.
KW - anterior lumbar interbody fusion
KW - lateral lumbar interbody fusion
KW - Lumbar Fusion
KW - morphine milligram equivalents
KW - opioids
KW - transforaminal lumbar interbody fusion
UR - http://www.scopus.com/inward/record.url?scp=85129174356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129174356&partnerID=8YFLogxK
U2 - 10.1177/21925682221089244
DO - 10.1177/21925682221089244
M3 - Article
C2 - 35379014
AN - SCOPUS:85129174356
SN - 2192-5682
VL - 13
SP - 2508
EP - 2515
JO - Global Spine Journal
JF - Global Spine Journal
IS - 8
ER -